Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

August 29, 2022

Study Completion Date

August 29, 2022

Conditions
Anemia, Hemolytic
Interventions
DEVICE

Hyperfine Portable MRI

The Hyperfine device is a newly developed MRI unit that has multiple potential advantages over standard CT or MRI including portability, easier upkeep, open design, and ease of use. Unlike CT, the Hyperfine device does not use moving parts or X-rays to generate images. Unlike routine MRI, the Hyperfine device uses two permanent magnets with open space between and around them, rather than a super-cooled superconducting magnetic tube. In contrast to CT and routine MRI, the device can be wheeled from place to place and moved into position with the patient remaining on a gurney or hospital bed. Relative to routine MRI, the device uses a very low magnetic field strength of 64 mT compared to 1.5 T or 3 T, making it safer for patients or environments with medical devices having metallic components.

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04721262 - Ferumoxytol Enhanced Hyperfine Low Field Strength MRI | Biotech Hunter | Biotech Hunter